Stockreport

Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF CRISPR Therapeutics AG (NASDAQ: CRSP ) ranks among the . Following the company's third-quarter financial results, Oppenheimer reaffirmed its Outperform rating and $95 pr [Read more]